Methods for treating cancer
AssigneeRadius Pharmaceuticals, Inc.
InventorsFiona GARNER, Gary HATTERSLEY
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of inhibiting tumor growth or producing tumor regression in a subject having a drug-resistant estrogen receptor alpha positive cancer or a mutant estrogen receptor alpha positive cancer. The methods entail administering to the subject a therapeutically effective amount of RAD1901 having the structure: or a salt or solvate thereof.
Claims17
A method of inhibiting tumor growth or producing tumor regression in a subject having a drug-resistant estrogen receptor alpha positive cancer comprising administering to said subject a therapeutically effective amount of RAD1901 having the structure:
- or a salt or solvate thereof.
A method of inhibiting tumor growth or producing tumor regression in a subject having a mutant estrogen receptor alpha positive cancer comprising administering to said subject a therapeutically effective amount of RAD1901 having the structure:
- or a salt or solvate thereof.
Dependencies are inferred from the claim text.